Logo image of FROG

JFROG LTD (FROG) Stock Fundamental Analysis

NASDAQ:FROG - Nasdaq - IL0011684185 - Common Stock - Currency: USD

38.53  -0.67 (-1.71%)

After market: 37.707 -0.82 (-2.14%)

Fundamental Rating

5

Taking everything into account, FROG scores 5 out of 10 in our fundamental rating. FROG was compared to 284 industry peers in the Software industry. FROG has a great financial health rating, but its profitability evaluates not so good. FROG is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year FROG was profitable.
In the past year FROG had a positive cash flow from operations.
FROG had negative earnings in each of the past 5 years.
In the past 5 years FROG always reported a positive cash flow from operatings.
FROG Yearly Net Income VS EBIT VS OCF VS FCFFROG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With a Return On Assets value of -6.13%, FROG perfoms like the industry average, outperforming 45.29% of the companies in the same industry.
FROG has a Return On Equity of -8.95%. This is comparable to the rest of the industry: FROG outperforms 49.64% of its industry peers.
Industry RankSector Rank
ROA -6.13%
ROE -8.95%
ROIC N/A
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
FROG Yearly ROA, ROE, ROICFROG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15

1.3 Margins

FROG's Gross Margin of 77.06% is fine compared to the rest of the industry. FROG outperforms 72.10% of its industry peers.
FROG's Gross Margin has been stable in the last couple of years.
FROG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
FROG Yearly Profit, Operating, Gross MarginsFROG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

8

2. Health

2.1 Basic Checks

FROG does not have a ROIC to compare to the WACC, probably because it is not profitable.
FROG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, FROG has more shares outstanding
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FROG Yearly Shares OutstandingFROG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
FROG Yearly Total Debt VS Total AssetsFROG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 7.40 indicates that FROG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.40, FROG is in the better half of the industry, outperforming 74.64% of the companies in the same industry.
FROG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 7.4
ROIC/WACCN/A
WACC13.99%
FROG Yearly LT Debt VS Equity VS FCFFROG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

FROG has a Current Ratio of 2.04. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
FROG's Current ratio of 2.04 is fine compared to the rest of the industry. FROG outperforms 60.87% of its industry peers.
FROG has a Quick Ratio of 2.04. This indicates that FROG is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.04, FROG is doing good in the industry, outperforming 61.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
FROG Yearly Current Assets VS Current LiabilitesFROG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.45% over the past year.
FROG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 178.78% yearly.
FROG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.46%.
The Revenue has been growing by 32.56% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)27.45%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)22.46%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%19.35%

3.2 Future

Based on estimates for the next years, FROG will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.21% on average per year.
Based on estimates for the next years, FROG will show a quite strong growth in Revenue. The Revenue will grow by 17.22% on average per year.
EPS Next Y7.28%
EPS Next 2Y12.31%
EPS Next 3Y16.21%
EPS Next 5YN/A
Revenue Next Year17.62%
Revenue Next 2Y17.13%
Revenue Next 3Y17.22%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FROG Yearly Revenue VS EstimatesFROG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
FROG Yearly EPS VS EstimatesFROG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 59.28, FROG can be considered very expensive at the moment.
FROG's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 29.63. FROG is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 55.26, which means the current valuation is very expensive for FROG.
The rest of the industry has a similar Price/Forward Earnings ratio as FROG.
FROG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 59.28
Fwd PE 55.26
FROG Price Earnings VS Forward Price EarningsFROG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, FROG is valued a bit cheaper than 69.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 39.88
EV/EBITDA N/A
FROG Per share dataFROG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FROG's earnings are expected to grow with 16.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.15
PEG (5Y)N/A
EPS Next 2Y12.31%
EPS Next 3Y16.21%

0

5. Dividend

5.1 Amount

No dividends for FROG!.
Industry RankSector Rank
Dividend Yield N/A

JFROG LTD

NASDAQ:FROG (2/21/2025, 8:21:44 PM)

After market: 37.707 -0.82 (-2.14%)

38.53

-0.67 (-1.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners74.1%
Inst Owner Change-4.19%
Ins Owners19.37%
Ins Owner Change-0.55%
Market Cap4.30B
Analysts81.48
Price Target46.06 (19.54%)
Short Float %3.59%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.09%
Min EPS beat(2)33.1%
Max EPS beat(2)39.08%
EPS beat(4)4
Avg EPS beat(4)21.01%
Min EPS beat(4)2.88%
Max EPS beat(4)39.08%
EPS beat(8)8
Avg EPS beat(8)50.92%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.46%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.25%
Revenue beat(4)1
Avg Revenue beat(4)-0.47%
Min Revenue beat(4)-2.47%
Max Revenue beat(4)1.25%
Revenue beat(8)2
Avg Revenue beat(8)-0.11%
Revenue beat(12)4
Avg Revenue beat(12)-0.06%
Revenue beat(16)5
Avg Revenue beat(16)-0.17%
PT rev (1m)0.76%
PT rev (3m)6.91%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-0.93%
EPS NY rev (1m)0%
EPS NY rev (3m)6.04%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 59.28
Fwd PE 55.26
P/S 10.03
P/FCF 39.88
P/OCF 38.75
P/B 5.56
P/tB 12.6
EV/EBITDA N/A
EPS(TTM)0.65
EY1.69%
EPS(NY)0.7
Fwd EY1.81%
FCF(TTM)0.97
FCFY2.51%
OCF(TTM)0.99
OCFY2.58%
SpS3.84
BVpS6.93
TBVpS3.06
PEG (NY)8.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.13%
ROE -8.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.06%
FCFM 25.15%
ROA(3y)-7.59%
ROA(5y)-6.33%
ROE(3y)-10.8%
ROE(5y)-8.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.15%
GM growth 5Y-0.97%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 14.65%
Cap/Sales 0.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 7.4
F-Score5
WACC13.99%
ROIC/WACCN/A
Cap/Depr(3y)19.73%
Cap/Depr(5y)42.11%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.45%
EPS 3Y178.78%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y7.28%
EPS Next 2Y12.31%
EPS Next 3Y16.21%
EPS Next 5YN/A
Revenue 1Y (TTM)22.46%
Revenue growth 3Y27.51%
Revenue growth 5Y32.56%
Sales Q2Q%19.35%
Revenue Next Year17.62%
Revenue Next 2Y17.13%
Revenue Next 3Y17.22%
Revenue Next 5YN/A
EBIT growth 1Y-25.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year55.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.34%
FCF growth 3Y67.17%
FCF growth 5Y67.4%
OCF growth 1Y49.58%
OCF growth 3Y58.42%
OCF growth 5Y61.81%